Pachymic acid, a novel compound for anti-rejection: effect in rats following cardiac allograft transplantation.
- Author:
Fan ZHANG
1
;
Xue-feng ZHANG
;
Bai-chun WANG
;
Hong-yu LIU
;
Chun-yu LI
;
Zong-hong LIU
;
Guo-wei ZHANG
;
Hang LÜ
;
Chao CHI
;
Fei WANG
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Apoptosis; drug effects; Graft Rejection; drug therapy; Heart Transplantation; Lymphocytes; drug effects; Male; Membrane Potential, Mitochondrial; drug effects; Rats; Rats, Sprague-Dawley; Rats, Wistar; Transplantation, Homologous; Triterpenes; therapeutic use
- From: Chinese Medical Journal 2009;122(23):2898-2902
- CountryChina
- Language:English
-
Abstract:
BACKGROUNDPachymic acid (PA), a natural triterpenoid, is known to significantly reduce cell proliferation and induce apoptosis in vitro through initiation of mitochondria dysfunction. However, its effect on immune cells and anti-rejection following organ transplantation remains unknown.
METHODSIn this study, we investigated PA as a treatment to control acute rejection occurred in rats which had accepted cardiac transplantation. We measured apoptosis of peripheral blood lymphocyte (PBLs), and CD4(+) lymphocyte, as well as the number of CD4(+) and CD8(+) lymphocytes and the effect of PA on acute rejection in rats 7 days after cardiac transplantation.
RESULTSPA treatment might decrease allograft rejection, protect PBLs from apoptosis, and reduce the percentage of CD8(+) lymphocyte. PA neither regulated the number nor the apoptosis rate of CD4(+) lymphocyte.
CONCLUSIONSOur findings indicated that PA has an anti-apoptotic effect acting on PBLs through a novel mechanism involving stabilization of the PBLs mitochondrial transmembrane potential, an anti-rejection effect in rats after cardiac transplantation and an inhibiting effect to CD8(+) lymphocyte.